Miyauchi S, Sawada Y, Iga T, Hanano M, Sugiyama Y
Department of Biophysics and Physicochemistry, Faculty of Pharmaceutical Sciences, University of Hokkaido, Sapporo, Japan.
Biol Pharm Bull. 1993 Aug;16(8):791-5. doi: 10.1248/bpb.16.791.
Glucagon has been demonstrated to stimulate the uptake of bile acid in isolated rat hepatocytes (Am. J. Physiol., 249, G427 (1985)). In the present study, we determined the influence of glucagon on the hepatic transport of a bile acid, taurocholate (TCA), in isolated rat livers. A single-pass perfusion and a rapid-injection, multiple indicator dilution method were employed. The hepatic availability at steady-state was 0.04. With the presence of glucagon in the perfusate (from 10(-9) to 10(-7) M), the bile flow rate was stimulated by 30%, while hepatic availability was decreased from 0.04 to 0.02 with a stepwise increase in glucagon concentration. Thirty min after the infusion of glucagon (300 nM), [3H]TCA and [14C]inulin were injected in a bolus state into the portal vein, and the outflow was collected at 1.0 s intervals over 30 s. Glucagon decreased the instantaneous hepatic availability by 50% compared to the control level, and was thus compatible with the steady-state experiments. In the control experiment, the influx clearance (PSinf) was 20 times higher than the efflux clearance (PSeff). Glucagon (300 nM) in the perfusate enhanced PSinf by 50% of the control, whereas sequestration clearance (CLseq) and the biliary excretion rate constant remained unchanged. PSeff was stimulated to 2 times the control, but still remained much smaller than CLseq. Based on the comparison of PSinf, PSeff and CLseq, the rate-determining process of TCA hepatic elimination was the influx process in both the presence and absence of glucagon. Taken together, the enhancement of the influx process was responsible for the decrease in TCA hepatic availability caused by glucagon.(ABSTRACT TRUNCATED AT 250 WORDS)
胰高血糖素已被证明能刺激分离的大鼠肝细胞摄取胆汁酸(《美国生理学杂志》,249卷,G427页(1985年))。在本研究中,我们测定了胰高血糖素对分离的大鼠肝脏中胆汁酸牛磺胆酸盐(TCA)肝转运的影响。采用了单程灌注和快速注射、多指示剂稀释法。稳态时的肝脏可利用性为0.04。当灌注液中存在胰高血糖素(浓度从10⁻⁹到10⁻⁷M)时,胆汁流速增加30%,而随着胰高血糖素浓度逐步升高,肝脏可利用性从0.04降至0.02。在注入胰高血糖素(300 nM)30分钟后,将[³H]TCA和[¹⁴C]菊粉以团注状态注入门静脉,并在30秒内每隔1.0秒收集流出液。与对照水平相比,胰高血糖素使瞬时肝脏可利用性降低了50%,因此与稳态实验结果相符。在对照实验中,流入清除率(PSinf)比流出清除率(PSeff)高20倍。灌注液中的胰高血糖素(300 nM)使PSinf比对照提高了50%,而滞留清除率(CLseq)和胆汁排泄速率常数保持不变。PSeff被刺激到对照的2倍,但仍远小于CLseq。基于PSinf、PSeff和CLseq的比较,无论有无胰高血糖素,TCA肝脏消除的限速过程都是流入过程。综上所述,流入过程的增强是胰高血糖素导致TCA肝脏可利用性降低的原因。(摘要截短至250字)